Business · 23/12/2002Updated: 10/17/2026 · 1 min read
FDA Corrects Notice on SoloPak Laboratories, Inc. Withdrawal of Drug Approval
Summary
The FDA is correcting a notice that withdrew approval of 1 new drug application and 38 abbreviated new drug applications held by SoloPak Laboratories, Inc., due to an error in the request process, and confirms that approval of NDA 19-961 for Ganite remains in effect.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →